首页> Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin> Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025.

Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025.

导出 OA

翻译打印收藏纠错

第一作者： Angela Mc,Rose

第一单位： Epiconcept, Paris, France.;These authors contributed equally as first authors.;These authors contributed equally to the writing of the paper.

作者： Angela Mc,Rose ^[1] ; Héloïse,Lucaccioni ^[2] ; Kimberly,Marsh ^[3] ; Freja,Kirsebom ^[4] ; Heather,Whitaker ^[4] ; Hanne-Dorthe,Emborg ^[5] ; Amanda,Bolt Botnen ^[6] ; Mark G,O'Doherty ^[7] ; Francisco,Pozo ^[8] ; Safraj Shahul,Hameed ^[3] ; Nick,Andrews ^[4] ; Mark,Hamilton ^[3] ; Ramona,Trebbien ^[6] ; Karina,Lauenborg Møller ^[9] ; Diogo Fp,Marques ^[10] ; Siobhan,Murphy ^[7] ; Ross,McQueenie ^[3] ; Jamie,Lopez-Bernal ^[4] ; Simon,Cottrell ^[11] ; Magda,Bucholc ^[7] ; Esther,Kissling ^[12] ; European IVE group ^[13] ; Members of the European IVE group

作者单位： Epiconcept, Paris, France.;These authors contributed equally as first authors.;These authors contributed equally to the writing of the paper. ^[1] Epiconcept, Paris, France.;These authors contributed equally as first authors. ^[2] Public Health Scotland, NHS Scotland, Glasgow, United Kingdom. ^[3] UK Health Security Agency, London, England. ^[4] Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark. ^[5] Department of Virology and Microbiological Preparedness, Statens Serum Institut, Copenhagen, Denmark. ^[6] Public Health Agency, Belfast, United Kingdom. ^[7] Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.;National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain. ^[8] Data Integration and Analyses, Statens Serum Institut, Copenhagen, Denmark. ^[9] Epiconcept, Paris, France. ^[10] Public Health Wales, Cardiff, Wales. ^[11] Epiconcept, Paris, France.;These authors contributed equally to the writing of the paper. ^[12] European Influenza Vaccine Effectiveness (IVE) group members are listed under Collaborators. ^[13]

关键词 Europe influenza multicentre study test-negative design vaccine effectiveness